Patricia Garcia-Lopez
Overview
Explore the profile of Patricia Garcia-Lopez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
441
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lujan-Mendez F, Garcia-Lopez P, Berumen L, Garcia-Alcocer G, Ferriz-Martinez R, Ramirez-Carrera A, et al.
Pharmaceuticals (Basel)
. 2025 Feb;
18(2).
PMID: 40006027
TBL-1, a recombinant lectin from , exhibit proapoptotic activity on colon cancer cells and inhibitory properties on colon tumorigenesis in vivo. Apoptosis has been associated with a phospho-EGFR/phospho-p38/phospho-p53 mechanistic axis....
2.
Llaguno-Munive M, Vazquez-Lopez M, Garcia-Lopez P
Int J Mol Sci
. 2024 Oct;
25(19).
PMID: 39409041
Within the field of nanomedicine, which is revolutionizing cancer treatment, solid lipid nanoparticles (SLNs) have shown advantages over conventional chemotherapy when tested on cancer cells in preclinical studies. SLNs have...
3.
Ocana-Arakachi K, Martinez-Herculano J, Jurado R, Llaguno-Munive M, Garcia-Lopez P
Pharmaceuticals (Basel)
. 2023 Oct;
16(10).
PMID: 37895808
Although cisplatin is an effective chemotherapy drug used against many types of cancer, it has poor bioavailability, produces severe adverse effects, and frequently leads to tumor resistance. Consequently, more effective...
4.
Llaguno-Munive M, Villalba-Abascal W, Aviles-Salas A, Garcia-Lopez P
J Imaging
. 2023 Oct;
9(10).
PMID: 37888319
Cancer is a public health problem requiring ongoing research to improve current treatments and discover novel therapies. More accurate imaging would facilitate such research. Near-infrared fluorescence has been developed as...
5.
Toro-Cordova A, Llaguno-Munive M, Jurado R, Garcia-Lopez P
Pharmaceutics
. 2022 Nov;
14(11).
PMID: 36432634
Cancer represents a very grave and quickly growing public health problem worldwide. Despite the breakthroughs in treatment and early detection of the disease, an increase is projected in the incidence...
6.
Prado-Carrillo O, Arenas-Ramirez A, Llaguno-Munive M, Jurado R, Perez-Rojas J, Cervera-Ceballos E, et al.
Int J Mol Sci
. 2022 Jul;
23(14).
PMID: 35887063
Chronic myeloid leukemia (CML) is a hematologic disorder characterized by the oncogene BCR-ABL1, which encodes an oncoprotein with tyrosine kinase activity. Imatinib, a BCR-ABL1 tyrosine kinase inhibitor, performs exceptionally well...
7.
Gonzalez-Mora A, Garcia-Lopez P
Int J Mol Sci
. 2021 Nov;
22(22).
PMID: 34830286
Hormonal factors may participate in the development and progression of glioblastoma, the most aggressive primary tumor of the central nervous system. Many studies have been conducted on the possible involvement...
8.
Llaguno-Munive M, Leon-Zetina S, Vazquez-Lopez I, Ramos-Godinez M, Medina L, Garcia-Lopez P
Front Oncol
. 2021 Apr;
11:675806.
PMID: 33828996
[This corrects the article DOI: 10.3389/fonc.2020.581814.].
9.
Llaguno-Munive M, Vazquez-Lopez M, Jurado R, Garcia-Lopez P
Front Oncol
. 2021 Mar;
11:606907.
PMID: 33680961
Glioma is the most common and aggressive primary tumor of the central nervous system. The standard treatment for malignant gliomas is surgery followed by chemoradiotherapy. Unfortunately, this treatment has not...
10.
Manzano-Leon N, Garcia-Lopez P
Eur J Pharmacol
. 2021 Jan;
896:173915.
PMID: 33513335
Ovarian cancer is frequently detected in advanced stages when the chances of survival are very low. Although chemotherapy is the treatment of choice, it is often rapidly compromised by the...